PremiumCompany AnnouncementsPulse Biosciences Earnings Call: Progress Amid Challenges Pulse Biosciences Inc. Reports 2024 Financial Results Closing Bell Movers: Lululemon falls 10% on soft guidance PremiumCompany AnnouncementsPulse Biosciences Appoints Paul LaViolette as CEO Pulse Biosciences announces Paul LaViolette as CEO Pulse announces publication of nano-PFA Cardiac Surgical System data PremiumThe FlyPulse Biosciences names Kenigsberg as Chief Medical Officer of Electrophysiology Pulse Biosciences reports Q3 EPS (21c) vs. (19c) last year Pulse Biosciences Highlights CellFX™ Advances in Presentation